According to two new studies presented Thursday at the San Antonio Breast Cancer Symposium, active monitoring of ductal ...
For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is noninferior to guideline-concordant care (GCC) ...
The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...
Two major studies challenge long-standing practices. The first shows active monitoring might safely replace surgery for some ...
Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...
An analysis of phase 3 trials found tamoxifen significantly reduced 15-year ipsilateral breast recurrence in patients with ...
A study based at Duke may change the standard of care for ductal carcinoma in situ (DCIS), known as stage zero breast cancer. A study based at Duke may change the standard of care for ductal ...
Ductal carcinoma in situ, or DCIS, accounts for up to 25% of diagnosed breast cancers and affects more than 50,000 women each year, according to the American Cancer Society. Often called ...
Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer ...
A 45-foot van in the parking lot of your child’s elementary school might seem an unlikely location for one of the most ...